OTC Markets OTCPK - Delayed Quote USD

SOHM, Inc. (SHMN)

Compare
0.0012 +0.0001 (+9.09%)
At close: August 30 at 3:57 PM EDT
Loading Chart for SHMN
DELL
  • Previous Close 0.0011
  • Open 0.0011
  • Bid 0.0011 x --
  • Ask 0.0012 x --
  • Day's Range 0.0011 - 0.0012
  • 52 Week Range 0.0008 - 0.0022
  • Volume 534,000
  • Avg. Volume 1,274,051
  • Market Cap (intraday) 2.293M
  • Beta (5Y Monthly) 0.73
  • PE Ratio (TTM) --
  • EPS (TTM) -0.0020
  • Earnings Date --
  • Forward Dividend & Yield --
  • Ex-Dividend Date --
  • 1y Target Est --

SOHM, Inc. develops, manufactures, markets, and distributes generic and private label pharmaceutical products in the United States. The company offers analgesics, antibiotics, anti-cold, and anti-inflammatory drugs, as well as over-the-counter, cosmeceuticals, and nutraceutical products. It also exports its products. The company has collaboration agreement with Coastar Therapeutics to advance in the field of genome editing using red blood cell membrane derived carriers and genome editing technology. SOHM, Inc. was founded in 2005 and is based in Corona, California.

www.sohm.com

145

Full Time Employees

December 31

Fiscal Year Ends

Recent News: SHMN

View More

Performance Overview: SHMN

Trailing total returns as of 8/30/2024, which may include dividends or other distributions. Benchmark is

.

YTD Return

SHMN
14.29%
S&P 500
18.42%

1-Year Return

SHMN
4.35%
S&P 500
25.59%

3-Year Return

SHMN
74.47%
S&P 500
25.26%

5-Year Return

SHMN
200.00%
S&P 500
93.14%

Compare To: SHMN

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: SHMN

View More

Valuation Measures

Annual
As of 8/30/2024
  • Market Cap

    2.29M

  • Enterprise Value

    2.29M

  • Trailing P/E

    --

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    --

  • Price/Book (mrq)

    --

  • Enterprise Value/Revenue

    --

  • Enterprise Value/EBITDA

    --

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    -87.26%

  • Return on Assets (ttm)

    -24.78%

  • Return on Equity (ttm)

    --

  • Revenue (ttm)

    1.3M

  • Net Income Avi to Common (ttm)

    -1.13M

  • Diluted EPS (ttm)

    -0.0020

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    182.56k

  • Total Debt/Equity (mrq)

    --

  • Levered Free Cash Flow (ttm)

    -561.14k

Research Analysis: SHMN

View More

Company Insights: SHMN

Research Reports: SHMN

View More

People Also Watch